We are live on ! Find out more
AXNX

Axonics, Inc. Common Stock

Delisted

AXNX was delisted on the 14th of November, 2024.

234 hedge funds and large institutions have $2.59B invested in Axonics, Inc. Common Stock in 2023 Q2 according to their latest regulatory filings, with 34 funds opening new positions, 93 increasing their positions, 84 reducing their positions, and 36 closing their positions.

New
Increased
Maintained
Reduced
Closed

11% more repeat investments, than reductions

Existing positions increased: 93 | Existing positions reduced: 84

1% less funds holding

Funds holding: 236234 (-2)

6% less first-time investments, than exits

New positions opened: 34 | Existing positions closed: 36

8% less capital invested

Capital invested by funds: $2.83B → $2.59B (-$238M)

27% less call options, than puts

Call options by funds: $1.01M | Put options by funds: $1.38M

100% less funds holding in top 10

Funds holding in top 10: 10 (-1)

Holders
234
Holders Change
-2
Holders Change %
-0.85%
% of All Funds
3.67%
Holding in Top 10
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
New
34
Increased
93
Reduced
84
Closed
36
Calls
$1.01M
Puts
$1.38M
Net Calls
-$369K
Net Calls Change
+$2.55M

AXNX Hedge Fund Activity: Q2 2023 in Review

234 of the 6,383 institutional investors tracked by Wall St. Rank reported a position in Axonics, Inc. Common Stock (AXNX) for Q2 2023, worth a combined $2.59B — down 8.4% from $2.83B a quarter earlier.

Sellers outnumbered buyers: 36 funds closed out of AXNX and 34 opened new positions — a net loss of 2 holders — while 84 trimmed existing stakes and 93 added.

The largest buyer was Braidwell, adding an estimated $21.7M. The largest seller was Point72 Asset Management, cutting an estimated $53.9M.

  • 234 institutional investors held Axonics, Inc. Common Stock (AXNX) as of Q2 2023, down from 236 in Q1 2023.
  • Funds reported $2.59B of Axonics, Inc. Common Stock stock for Q2 2023, down 8.4% quarter-over-quarter.
  • 34 funds opened new Axonics, Inc. Common Stock positions in Q2 2023 and 36 closed out, a net change of -2 holders.
  • The largest Axonics, Inc. Common Stock buyer in Q2 2023 was Braidwell, an estimated $21.7M added.
  • The largest Axonics, Inc. Common Stock seller in Q2 2023 was Point72 Asset Management, an estimated $53.9M sold.

Based on aggregated 13F filings for Q2 2023.